Drug class
Cephalosporins - 3rd Generation
Third-generation cephalosporins are a therapeutic class of broad-spectrum beta-lactam antibacterial agents, including drugs such as ceftriaxone, cefotaxime, and ceftazidime. Read more about Cephalosporins - 3rd Generation
66 drugs in this class 38 manufacturers
Drugs in Cephalosporins - 3rd Generation
CEFDINIR
CEFPODOXIME PROXETIL
CEFPODOXIME PROXETIL
CEFTRIAXONE (ceftriaxone sodium in iso-osmotic dextrose)
CEFPODOXIME PROXETIL
CEFPODOXIME PROXETIL
CEFTAZIDIME
CEFDINIR
Third-generation cephalosporins are a therapeutic class of broad-spectrum beta-lactam antibacterial agents, including drugs such as ceftriaxone, cefotaxime, and ceftazidime.
They exert bactericidal activity by binding to penicillin-binding proteins, thereby disrupting bacterial peptidoglycan cell wall synthesis.
Relative to earlier generations, these agents offer significantly enhanced stability against beta-lactamases and expanded coverage against gram-negative pathogens, alongside substantial cerebrospinal fluid penetration.
Consequently, they serve a central therapeutic role in treating moderate to severe systemic infections, including bacterial meningitis, lower respiratory tract infections, pyelonephritis and complicated urinary tract infections, intra-abdominal sepsis, and gonorrhea.
-
picmonic.com
Third-generation cephalosporins are a therapeutic class of broad-spectrum beta-lactam antibacterial agents, including drugs such as ceftriaxone, cefotaxime, and ceftazidime They exert bactericidal activity by binding to penicillin-binding proteins, thereby disrupting bacterial peptidoglycan cell wall synthesis Relative to earlier generations, these agents offer significantly enhanced stability against beta-lactamases and expanded coverage against gram-negative pathogens, alongside substantial ce...
-
nih.gov
Third-generation cephalosporins are a therapeutic class of broad-spectrum beta-lactam antibacterial agents, including drugs such as ceftriaxone, cefotaxime, and ceftazidime They exert bactericidal activity by binding to penicillin-binding proteins, thereby disrupting bacterial peptidoglycan cell wall synthesis Consequently, they serve a central therapeutic role in treating moderate to severe systemic infections, including bacterial meningitis, lower respiratory tract infections, pyelonephritis a...
-
nih.gov
Relative to earlier generations, these agents offer significantly enhanced stability against beta-lactamases and expanded coverage against gram-negative pathogens, alongside substantial cerebrospinal fluid penetration Consequently, they serve a central therapeutic role in treating moderate to severe systemic infections, including bacterial meningitis, lower respiratory tract infections, pyelonephritis and complicated urinary tract infections, intra-abdominal sepsis, and gonorrhea
-
fda.gov
Consequently, they serve a central therapeutic role in treating moderate to severe systemic infections, including bacterial meningitis, lower respiratory tract infections, pyelonephritis and complicated urinary tract infections, intra-abdominal sepsis, and gonorrhea
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.